SpaceX
SPCX
$167.60
-2.51%
Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and operates reusable rocket systems for government and commercial launch customers, and since 2019 has built the Starlink satellite constellation into a global mobile broadband business; in early 2026 it acquired xAI, adding the Grok large language model, the Colossus gigawatt-scale data center, and the X social network to its portfolio. The company is the dominant Western launch provider and the largest satellite broadband operator, giving it a vertically integrated platform spanning launch, connectivity, and now artificial intelligence infrastructure. The current investor narrative is dominated by the June 2026 IPO and its explosive post-listing performance, the transformative but capital-hungry xAI acquisition, and a debate over whether the roughly $1.06 trillion market capitalization is justified by a business still posting net losses. Recent headlines highlight a pullback from the $225 post-IPO high, upcoming December lock-up expirations, and the Federal Reserve's first rate hike in three years, which has shifted the market's focus from growth-at-any-cost toward profitability and self-funding.…
SPCX
SpaceX
$167.60
Related headlines
Investment Opinion: Should I buy SPCX Today?
The synthesized recommendation is a Hold with a speculative tilt. The core thesis is that SpaceX is a category-defining company with unrivaled launch and satellite broadband assets, but its current valuation of $1.06 trillion already prices in near-flawless execution of a capital-intensive AI and Starlink strategy that has yet to prove profitable. The analyst consensus is 'buy' with a mean rating of 1.68 and an average target of $226.04, implying 42.2% upside, but the wide target range ($140-$450) and negative trailing earnings suggest high uncertainty.
Supporting evidence for a Hold includes: (1) revenue growth of 91.9% YoY in Q2 2026, which is exceptional but may decelerate as the company laps the xAI acquisition; (2) gross margin expansion to 55.27%, yet operating margin remains negative at -1.83% due to $3.548 billion in quarterly R&D; (3) a forward PE of 91.19x, which is extremely high and relies on EPS of $4.4765 that is far above the current quarterly EPS of -$0.09; and (4) a negative free cash flow of -$15.95 billion, requiring continued external financing. The $94 billion cash pile provides a cushion, but the burn rate is unsustainable without eventual profitability.
The biggest risks that could invalidate the thesis are: (1) a failure to achieve the projected EPS ramp, which would make the 91x forward PE untenable; (2) lock-up expirations in December 2026 creating a supply overhang that depresses the stock; and (3) a Fed rate hike cycle that compresses growth multiples. The rating would upgrade to Buy if the stock pulls back to the $120-$130 range (implying a PS below 20x) or if the company demonstrates a clear path to positive free cash flow. It would downgrade to Sell if revenue growth decelerates below 30% YoY or if free cash flow remains below -$10 billion per quarter without a credible funding plan. Relative to its own history, the PS of 25.22x is near the low end of its short public life (down from 133x in Q1 2026), but relative to peers, it remains vastly overvalued. The stock is overvalued on current fundamentals but may be fairly valued if the growth trajectory persists.
Sign up to view all
SPCX 12-Month Price Forecast
The risk/reward is balanced but highly uncertain. The bull case is supported by explosive revenue growth, expanding gross margins, and a strong analyst consensus, while the bear case is anchored by extreme valuation, massive cash burn, and near-term lock-up overhang. The key tension is whether the company can achieve the projected EPS of $4.48 within twelve months to justify the 91x forward PE; if it does, the stock could reach $300-$450, but if it fails, downside to $104-$140 is likely. I would upgrade to bullish if the stock pulls back to the $120-$130 range (implying a PS below 20x) or if free cash flow turns positive. I would downgrade to bearish if revenue growth decelerates below 30% YoY or if the company announces a dilutive equity raise at depressed prices.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SpaceX's 12-month outlook, with a consensus price target around $227.54 and implied upside of +35.8% versus the current price.
Average Target
$227.54
0 analysts
Implied Upside
+35.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$140 - $450
Analyst target range
Coverage is robust for a recent IPO, with 25 analysts and a consensus recommendation of "buy" (recommendation mean of 1.68, where 1.0 is a strong buy). The average target price is $226.04, which against the current price of $158.96 implies approximately 42.2% upside, a strongly bullish consensus that stands in contrast to the stock's 46.35% drawdown from its high. The consensus leans clearly bullish, with the institutional ratings list showing predominantly Buy/Outperform actions from Macquarie, Deutsche Bank, Wells Fargo, Oppenheimer, Wolfe Research, UBS, Needham, and Cantor Fitzgerald, and only MoffettNathanson at Neutral; notably, Argus Research upgraded from Hold to Buy on 2026-08-07, suggesting analyst sentiment has been improving even as the stock price corrected. The target range is exceptionally wide, from a low of $140.00 to a high of $450.00, a spread of $310 or roughly 2.2x the current price, which signals very high uncertainty and low conviction on the precise earnings path. The high target of $450.00 implies roughly 183% upside and would require aggressive multiple expansion plus successful AI monetization and Starlink scaling toward the $306.68 billion high end of estimated revenue; the low target of $140.00 implies about 11.9% downside and prices in margin compression, continued cash burn, and lock-up-driven selling pressure. The wide spread, combined with the December 2026 lock-up expirations highlighted in recent news, means near-term price action may be driven more by share supply dynamics than by fundamental reassessment, and the estimated EPS range of $0.30 to $7.76 further underscores how little consensus exists on the company's near-term profitability.
Drowning in data?
Find the real signal!
Bulls vs Bears: SPCX Investment Factors
The bull case rests on explosive revenue growth (91.9% YoY), expanding gross margins (55.27%), a strong analyst consensus (42.2% upside to $226.04), and a massive $94 billion cash pile that funds the capital-intensive AI and Starlink buildout. The bear case centers on extreme valuation (25.22x PS, 166.78x EV/Sales), massive cash burn (-$15.95 billion FCF), upcoming lock-up expirations, and an unproven AI strategy that faces intense competition and a newly hawkish Fed. Currently, the bear evidence appears stronger because the valuation is disconnected from current profitability, and near-term supply dynamics from lock-ups could overwhelm fundamental progress. The single most important tension is whether the company can achieve the estimated $4.48 EPS within the next twelve months to justify the 91x forward PE; if it fails, the stock could re-rate sharply lower, but if it succeeds, the upside to $450 is substantial.
Bullish
- Explosive Revenue Growth: Q2 2026 revenue surged 91.9% year-over-year to $7.814 billion, up from $4.071 billion in Q2 2025, and accelerated 66.5% sequentially from Q1 2026. This growth is driven by AI Solutions & Infrastructure ($2.194 billion) and Starlink Consumer ($2.485 billion), which together now account for 60% of total revenue, demonstrating successful diversification beyond launch services.
- Gross Margin Expansion: Gross margin expanded to 55.27% in Q2 2026, up from 49.13% in Q1 2026 and 43.94% in Q2 2025. This 11.3 percentage point year-over-year improvement reflects operating leverage as Starlink and AI infrastructure scale, and suggests a path to profitability if operating expenses are contained.
- Strong Analyst Consensus: 25 analysts rate the stock a 'buy' with a mean recommendation of 1.68 (1.0 = strong buy) and an average target price of $226.04, implying 42.2% upside from the current $158.96. The consensus is overwhelmingly bullish, with only one neutral rating and recent upgrades such as Argus Research's Hold-to-Buy on 2026-08-07.
- Massive Cash Runway: The company holds $94.352 billion in cash following an $85.88 billion equity raise in Q2 2026, with a current ratio of 1.45 and debt-to-equity of just 0.55. This liquidity provides substantial runway to fund the $18.369 billion quarterly capex program and negative free cash flow of -$15.95 billion without immediate solvency risk.
Bearish
- Extreme Valuation Multiples: The stock trades at a price-to-sales ratio of 25.22x and an EV/Sales of 166.78x, which is 8-25x higher than mature aerospace primes that typically trade at 1x-3x sales. The forward PE of 91.19x leaves no room for execution error and prices in flawless AI monetization and Starlink scaling.
- Massive Cash Burn: Free cash flow was -$15.95 billion in Q2 2026 and -$9.06 billion in Q1 2026, driven by $18.369 billion in quarterly capital expenditures. The company is entirely dependent on external financing, having raised $93.166 billion net in Q2 alone, and any tightening of capital markets could force a strategic pivot.
- Lock-Up Expiration Overhang: December 2026 lock-up expirations will release a massive supply of insider shares, potentially pressuring the stock. Recent news highlights this as a key risk, with the stock already 46.35% below its post-IPO high of $225.64, and the overhang may keep the stock rangebound in the near term.
- Unproven AI Strategy: The xAI acquisition added Grok, Colossus, and X, but the AI business is unproven at scale and faces intense competition from well-capitalized rivals. The $3.548 billion quarterly R&D expense reflects the high cost of competing, and there is no guarantee that AI investments will generate positive returns.
SPCX Technical Analysis
SPCX is in a powerful but highly immature uptrend, having listed on 2026-06-12 at $160.95 and closing most recently at $158.96, essentially flat versus its debut but up 532.54% over the trailing year and 628.84% year-to-date. The stock trades at roughly 45.9% of its 52-week range of $104.83 to $225.64, meaning it sits in the lower-middle portion of its post-IPO band despite the enormous annual gain, a direct consequence of the 46.35% maximum drawdown from the $225.64 peak. That positioning signals a stock in a volatile post-IPO digestion phase rather than a clean momentum breakout, with the long-term trend intact but intermediate momentum damaged. Recent momentum has turned constructive: the stock is up 12.97% over the past month versus a 0.59% gain for SPY, a relative strength of 12.38 percentage points, and it jumped 7.35% on the most recent session from $148.07 to $158.96 on volume of 119.1 million shares. However, the 3-month change is -1.88% against SPY's +3.34%, a relative strength of -5.22 points, revealing a clear divergence in which the one-month rebound is fighting a three-month downtrend that followed the June spike to $225.64. This pattern is consistent with a mean-reversion bounce within a broader consolidation rather than a confirmed trend reversal, and the 2.07 short ratio suggests short sellers are not yet aggressively pressing the position. Key technical levels are well defined: support sits at the 52-week low of $104.83, which also marks the area of the July-August basing zone around $108-$115, while resistance is the $225.64 post-IPO high, with intermediate resistance near the $160-$165 area where the stock has repeatedly stalled. A decisive breakout above $165 would open the path toward the $200-$225 zone and signal that the lock-up overhang is being absorbed, whereas a breakdown below $104.83 would confirm a failed IPO pattern and likely trigger momentum-driven selling; with a maximum drawdown already at 46.35%, position sizing should assume extreme volatility regardless of the beta figure, which is not available in the provided data.
Beta
—
—
Max Drawdown
-46.4%
Largest decline past year
52-Week Range
$105-$226
Price range past year
Annual Return
+563.8%
Cumulative gain past year
| Period | SPCX Return | S&P 500 |
|---|---|---|
| 1m | +13.3% | +0.9% |
| 3m | +10.1% | +3.4% |
| 6m | +662.5% | +14.4% |
| 1y | +563.8% | +16.2% |
| ytd | +668.5% | +14.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SPCX Fundamental Analysis
Revenue is growing rapidly but unevenly: Q2 2026 revenue reached $7.814 billion, up 91.9% from $4.071 billion in Q2 2025, and up 66.5% sequentially from $4.694 billion in Q1 2026. The segment mix shows the growth engine is no longer launch alone, with AI Solutions & Infrastructure contributing $2.194 billion, Consumer (Starlink) $2.485 billion, Enterprise & Government $1.806 billion, Launch Services $648 million, Launch & Development $314 million, and Advertising $367 million. The sequential acceleration from Q1 to Q2, combined with the xAI consolidation, implies the AI and Starlink businesses are now the primary growth drivers while the legacy launch business is a smaller but strategically critical piece; the key question for the investment case is whether this revenue trajectory can be sustained as the company absorbs massive AI capital spending. Profitability remains elusive: Q2 2026 net income was -$541 million on a net margin of -6.92%, an improvement from -$4.276 billion and a -91.10% net margin in Q1 2026 and from -$1.008 billion and -24.76% in Q2 2025. Gross margin is a genuine strength at 55.27% in Q2 2026, up from 49.13% in Q1 2026 and 43.94% in Q2 2025, but operating margin is still -1.83% and the trailing net margin is -26.44%, with operating income of -$143 million reflecting $3.548 billion of quarterly R&D and $4.462 billion of total operating expenses. The margin trajectory is improving at the gross line but the company remains unprofitable, and the gap between 55% gross margin and negative operating margin is entirely explained by the enormous fixed and research cost base required to fund Starship, Starlink expansion, and AI infrastructure. The balance sheet is liquid but cash-consumptive: the current ratio is 1.45, cash at end of Q2 2026 was $94.352 billion following an $85.88 billion common stock issuance, and debt-to-equity is 0.55, but free cash flow was -$15.95 billion in Q2 2026 and -$9.06 billion in Q1 2026, driven by $18.369 billion of quarterly capital expenditure. Operating cash flow was positive at $2.419 billion in Q2 2026, but ROE is -11.95% and the company is clearly dependent on external financing, having raised $93.166 billion net from financing in Q2 alone; the FCF yield is deeply negative and the cash burn is the single largest fundamental risk, though the $94 billion cash pile provides a substantial runway.
Quarterly Revenue
$7.8B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
55.3%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SPCX Overvalued?
Because trailing net income is negative (-$541 million in Q2 2026, with a trailing PE of -95.24), the PE ratio is not meaningful, so the primary metric is the price-to-sales ratio of 25.22x, with EV/Sales at 166.78x and EV/EBITDA at 246.39x as secondary checks. The forward PE of 91.19x against estimated EPS of $4.4765 is the most informative forward-looking metric, and the enormous gap between the negative trailing PE and the positive 91x forward PE implies the market expects a dramatic swing to profitability within the next twelve months. The PEG ratio of 0.0035 is distorted by the near-zero trailing earnings base and should be disregarded; the price-to-book of 11.40x and price-to-cash-flow of 69.41x confirm the stock is priced for exceptional future cash generation rather than current fundamentals. Peer comparison is difficult because the provided valuation data does not include an explicit industry average, but the absolute multiples are extreme even for high-growth aerospace and defense: a PS of 25.22x versus a sector where mature primes typically trade in the 1x-3x range represents a premium of roughly 8-25x, and the EV/Sales of 166.78x is an order of magnitude above anything in traditional aerospace. This premium can only be justified if the AI and Starlink businesses scale to the $198.5 billion average estimated revenue level and deliver the estimated $4.48 in EPS, meaning the valuation is a pure bet on flawless execution of a capital-intensive, unproven-at-scale AI strategy. Historically, the stock's own ratios show rapid compression: PS was 133.18x in Q1 2026 and 128.22x in Q2 2026 on the historical ratios data versus the current 25.22x, and PB fell from 15.03x in Q1 2026 to 7.88x in Q2 2026, indicating that as revenue and book value have grown, the multiples have normalized sharply from post-IPO extremes. The current PS of 25.22x is therefore near the low end of the stock's short public history, which could represent a value opportunity if growth persists, or a warning that the market is repricing the company toward more realistic assumptions as lock-up expirations approach.
PE
-95.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
246.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are severe. The company burned -$15.95 billion in free cash flow in Q2 2026 alone, with capital expenditures of $18.369 billion, and has negative operating and net margins of -1.83% and -6.92%, respectively. Despite a $94.35 billion cash balance, the current burn rate implies that without continued access to capital markets, the runway is finite. Additionally, revenue is concentrated in capital-intensive segments (AI and Starlink) that require ongoing heavy investment, and the company has a debt-to-equity of 0.55, which, while manageable, adds fixed obligations. The interest expense of $629 million in Q2 2026 further pressures profitability.
Market and competitive risks are elevated. The stock trades at a PS of 25.22x and EV/Sales of 166.78x, leaving it highly vulnerable to valuation compression if growth decelerates or if the Fed's rate hike cycle continues. The beta is not provided, but the stock's 46.35% max drawdown and 532% one-year gain indicate extreme volatility. Competitive threats are intensifying: Rocket Lab is expanding via acquisitions, and the AI landscape is crowded with well-funded players like Anthropic (upcoming IPO) and established tech giants. Regulatory risks, such as spectrum allocation for Starlink and AI regulation, could also impact operations. Recent news highlights the Fed's rate hike and the shift toward profitability, which could trigger sector rotation away from unprofitable growth stocks like SPCX.
Worst-case scenario: A combination of a failed Starship milestone, slower Starlink subscriber growth, and a disappointing AI monetization could lead to a sharp revenue miss, causing the stock to retest its 52-week low of $104.83, which is 34% below the current price of $158.96. If lock-up expirations flood the market with shares and analyst downgrades follow, the stock could fall to the analyst low target of $140, but a more dire scenario would see it break below $104.83, potentially down to the July-August basing zone around $108-$115. From the current price, an investor could lose 34% to the 52-week low, and if the company's cash burn forces a dilutive equity raise at depressed prices, the downside could exceed 50%.
FAQ
The key risks are ranked by severity: (1) Financial risk: The company burned -$15.95 billion in free cash flow in Q2 2026 and has negative net income of -$541 million. It relies on external financing, having raised $93.166 billion in Q2 alone, and any tightening of capital markets could force a dilutive equity raise. (2) Valuation risk: The stock trades at 25.22x sales and 91.19x forward earnings, leaving it vulnerable to multiple compression if growth slows or if the Fed continues hiking rates. (3) Competitive risk: The AI and satellite broadband markets are intensely competitive, with well-funded rivals like Anthropic (upcoming IPO) and Rocket Lab expanding. (4) Company-specific risk: The December 2026 lock-up expiration could flood the market with insider shares, pressuring the stock price. Additionally, the xAI acquisition is unproven and could distract management from core operations.
Our 12-month forecast has three scenarios: Bull case (25% probability) targets $300-$450, assuming successful Starship flights, Starlink subscriber growth, and AI monetization, with revenue reaching $306.68 billion and EPS of $7.76. Base case (50% probability) targets $200-$250, assuming steady execution with revenue of $198.47 billion and EPS of $4.48, and a forward PE of 50-60x. Bear case (25% probability) targets $104.83-$140, assuming execution missteps, revenue of $127.31 billion, EPS of $0.30, and continued macro headwinds. The most likely scenario is the base case, which implies a 26-57% upside from the current price of $158.96. The key assumption is that the company can achieve the consensus EPS estimate of $4.48, which would justify a higher stock price despite the high multiple.
SPCX appears significantly overvalued on current fundamentals. The price-to-sales ratio is 25.22x, compared to mature aerospace primes that typically trade at 1x-3x sales, and the EV/Sales is 166.78x. The forward PE of 91.19x is also extremely high, especially given that trailing EPS is negative (-$0.01). However, the valuation is not without justification: revenue is growing at 91.9% YoY, and the company is investing heavily in AI and Starlink, which could drive future earnings. The market is pricing in flawless execution of these growth initiatives, as evidenced by the estimated EPS of $4.4765 for the next twelve months. If the company meets these estimates, the stock could be fairly valued, but any shortfall would likely lead to a sharp re-rating. Relative to its own history, the PS of 25.22x is near the low end of its short public life (down from 133x in Q1 2026), suggesting that the market has already repriced it lower, but it remains expensive compared to peers.
SPCX is a high-risk, high-reward investment that is not suitable for all investors. The bull case is compelling: revenue grew 91.9% YoY in Q2 2026, gross margins expanded to 55.27%, and analysts have a 'buy' consensus with a $226.04 average target (42.2% upside). However, the bear case is equally strong: the stock trades at 25.22x sales and 91.19x forward earnings, while free cash flow is -$15.95 billion and net income is -$541 million. The upcoming December lock-up expiration could pressure the stock, and the Fed's rate hike cycle poses a macro risk. For aggressive investors with a long-term horizon and tolerance for volatility, a small position could be justified, but conservative investors should avoid until there is a clearer path to profitability.
SPCX is more suitable for long-term investment (5+ years) than short-term trading. The company is in a capital-intensive growth phase, with negative free cash flow and unproven AI and Starlink economics, so near-term volatility is likely to remain extreme (46.35% max drawdown already). The stock does not pay a dividend (payout ratio 0%) and has a short ratio of 2.07, indicating that short sellers are not aggressively pressing, but the lock-up expiration in December 2026 could create a short-term overhang. For long-term investors, the potential for SpaceX to dominate launch, satellite broadband, and AI infrastructure could yield substantial returns, but only if the company successfully executes its vision. A minimum holding period of 3-5 years is recommended to ride out the volatility and allow the growth story to unfold. Short-term traders may find opportunities around earnings and lock-up events, but the risk of sharp drawdowns is high.